Accreditation of flow cytometry in Europe
Open Access
- 28 March 2013
- journal article
- research article
- Published by Wiley in Cytometry Part B: Clinical Cytometry
- Vol. 84B (3) , 135-142
Abstract
ISO 15189 has been introduced to enable any clinical laboratory, irrespective of geographic location, to be accredited against internationally recognized standards and therefore facilitate direct international comparison of laboratories. Together with increasing use of ISO 15189 for standardization and competition purposes, often triggered by demands of patients and clinicians, clinical flow cytometry laboratories are becoming increasingly challenged to introduce compliant quality management systems. Whilst in most countries, ISO 15189 accreditation is not yet compulsory, there is increasing evidence to suggest that the implementation of this standard is growing. As a result, the European Society of Clinical Cell Analysis (ESCCA) has analysed the impact of accreditation in clinical flow cytometry laboratories. It found, through a discussion forum, that staff qualification, adaptation of multicolour antibody panels, and implementation of a comprehensive quality system (including quality assessment) have been identified as major challenges. © 2013 International Clinical Cytometry SocietyKeywords
This publication has 9 references indexed in Scilit:
- Issue Highlights-May 2012Cytometry Part B: Clinical Cytometry, 2012
- Regulation of Medical Devices in the United States and European UnionNew England Journal of Medicine, 2012
- ISHAGE protocol: Are we doing it correctly?Cytometry Part B: Clinical Cytometry, 2011
- Minimum information about a flow cytometry experiment (MIFlowCyt) checklist (Numbered in accordance with MIFlowCyt 1.0 document)Cytometry Part A, 2010
- ISO 15189 accreditation: Requirements for quality and competence of medical laboratories, experience of a laboratory IIClinical Biochemistry, 2009
- ISO 15189 Accreditation: Requirements for quality and competence of medical laboratories, experience of a laboratory IClinical Biochemistry, 2009
- 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: Optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasiaCytometry Part B: Clinical Cytometry, 2007
- 2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: Medical indicationsCytometry Part B: Clinical Cytometry, 2007
- Accreditation of Medical Laboratories in Europe: Statutory Framework, Current Situation and PerspectivesTransfusion Medicine and Hemotherapy, 2006